Cancer Vaccine Institute News

At the 2025 San Antonio Breast Cancer Symposium, the UW Cancer Vaccine Institute shared new research revealing how a unique population of immune cells, shaped in part by the gut microbiome, may influence breast cancer growth and treatment response. Our team’s findings shed light on these immune cells called BAC‑TA T cells, their presence in newly diagnosed patients, and how precision probiotics could one day help shift the immune environment to better fight tumors. Dr. Denise

The UW Cancer Vaccine Institute is excited to share new findings suggesting that a HER2-targeted cancer vaccine may help protect HER2-positive breast cancer patients from developing brain metastases—one of the most difficult complications to treat. Dr. Candace Haghighi presented these findings at the 2025 San Antonio Breast Cancer Symposium. Dr. Candace B. Haghighi at the 2025 San Antonio Breast Cancer Symposium The Highlights: HER2-positive breast cancer has a high risk of s

Photo Credits: Jennifer Childs and Kiran Dhillon The Cancer Vaccine Institute held our first ever patient reunion during the CVI Circle -...

We're delighted to announced that two Cancer Vaccine Institute faculty have been awarded funding by the Andy Hill Cancer Research...

From top left to bottom right: Dr. Raymonda Johnson, Dr. Kiran Dhillon, Glorianne Jackson, Marilyn Lacy, Dr. Shaveta Vinayak, Dr. Nora...